Stockscreener 앱 받기
5.79
1.03%
-0.06
시간 외 거래:
5.79
전일 마감가:
$5.85
열려 있는:
$5.83
하루 거래량:
207.88K
Relative Volume:
0.54
시가총액:
$364.13M
수익:
$198.53M
순이익/손실:
$-63.68M
주가수익비율:
-5.6643
EPS:
-1.0222
순현금흐름:
$-41.50M
1주 성능:
-6.76%
1개월 성능:
+6.43%
6개월 성능:
-33.52%
1년 성능:
-31.40%
1일 변동 폭
$5.77
$5.99
1주일 범위
$5.70
$6.20
52주 변동 폭
$4.54
$10.79
트리스 메디컬 컨셉트 Stock (TMCI) Company Profile
명칭
Treace Medical Concepts Inc
전화
(904) 373-5940
주소
100 PALMETTO PARK PLACE, PONTE VEDRA
TMCI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
5.79 | 390.64M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
120.51 | 232.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.65 | 153.66B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
388.90 | 150.87B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.53 | 114.55B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.18 | 46.22B | 5.54B | 4.18B | 623.10M | 7.00 |
트리스 메디컬 컨셉트 Stock (TMCI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-04 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2024-12-31 | 개시 | Lake Street | Buy |
| 2024-12-17 | 재개 | JP Morgan | Neutral |
| 2024-05-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-05-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-08 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-05-08 | 다운그레이드 | Truist | Buy → Hold |
| 2023-09-29 | 개시 | UBS | Buy |
| 2023-05-01 | 개시 | Truist | Buy |
| 2023-04-11 | 개시 | Stephens | Equal-Weight |
| 2022-05-12 | 개시 | BTIG Research | Buy |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | 개시 | JP Morgan | Overweight |
| 2021-05-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-05-18 | 개시 | SVB Leerink | Outperform |
| 2021-05-18 | 개시 | Stifel | Buy |
모두보기
트리스 메디컬 컨셉트 주식(TMCI)의 최신 뉴스
Important Notice to Long-Term Shareholders of Centene - GlobeNewswire
Kornitzer Capital Management Inc. KS Sells 161,525 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
What makes Treace Medical Concepts Inc. stock price move sharplyReal Time Breakout Tracking - Newser
How Treace Medical Concepts Inc. stock performs during market volatilitySafer Investing With Bigger Upside - Newser
Why Treace Medical Concepts Inc. stock attracts strong analyst attentionQuick Profit Idea Stream - Newser
Important Notice to Long-Term Shareholders of Methode - GlobeNewswire
Important Notice to Long-Term Shareholders of Methode Electronics, Inc. (NYSE: MEI); Manhattan Associates, Inc. (NASDAQ: MANH); Napco Security Technologies, Inc. (NASDAQ: NSSC); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Offi - TradingView
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Stockholders to Connect - ACCESS Newswire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.16 Consensus PT from Analysts - MarketBeat
Important Notice to Long-Term Shareholders of CorMedix Inc. - GlobeNewswire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Recommendation of “Hold” by Analysts - Defense World
Lisanti Capital Growth LLC Buys Shares of 252,215 Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Notice to Long-Term Shareholders of Maison Solutions Inc. - GlobeNewswire
Notice to Long-Term Shareholders of MicroStrategy, Inc. - GlobeNewswire
GAMMA Investing LLC Buys 10,236 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Grabar Law Office Investigates Claims on Behalf of - GlobeNewswire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) is favoured by institutional owners who hold 53% of the company - Yahoo Finance
Notice to Long-Term Shareholders of Manhattan Associates, - GlobeNewswire
Treace Sues Zimmer and Paragon 28 Over Patents - Orthopedics This Week
Notice to Long-Term Shareholders of Blue Ridge Bankshares, - GlobeNewswire
In the wake of Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) latest US$46m market cap drop, institutional owners may be forced to take severe actions - simplywall.st
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Maison Solutions Inc. (NASDAQ: MSS); Methode Electronics, Inc. (NYSE: MEI); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Xponential Fitness Inc. (NYSE: XPOF) - Business Upturn
Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) Price Target at $10.16 - MarketBeat
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.16 Consensus Target Price from Analysts - Defense World
Squarepoint Ops LLC Sells 52,890 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Manhattan Associates, Inc. (NASDAQ: MANH); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VIRT) - GlobeNewswire Inc.
California State Teachers Retirement System Sells 37,890 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Attention Long-Term Investors of Manhattan Associates, Inc. - GlobeNewswire
Attention Long-Term Investors of Manhattan Associates, Inc. (NASDAQ: MANH); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) – Grabar Law Office is Investigating Claims - TradingView
Attention Long-Term Investors of AppLovin Corporation - GlobeNewswire
Kuehn Law Encourages Investors of Treace Medical Concepts, Inc. to Contact Law Firm - Kilgore News Herald
Securities Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (TMCI)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Treace Medical Concepts, Inc. Investors: Please contact the - GlobeNewswire
Securities Fraud Class Action Filed Against Treace Medical Concepts, Inc. (TMCI)Levi & Korsinsky Reminds Investors of June 10, 2025 - ACCESS Newswire
TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Lost Money on Treace Medical Concepts, Inc. (TMCI)? Join Class Action Before June 10, 2025Contact Levi & Korsinsky - ACCESS Newswire
Class Action Filed Against Treace Medical Concepts, Inc. - GlobeNewswire
Class Action Filed Against Treace Medical Concepts, Inc. (TMCI)June 10, 2025 Deadline to ... - Bluefield Daily Telegraph
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical - Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical ... - Bluefield Daily Telegraph
Treace Medical Concepts files patent infringement suit against Zimmer Biomet - Med-Tech Insights
Squarepoint Ops LLC Has $137,000 Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 10, 2025 in Treace Medical Concepts, Inc. LawsuitTMCI - marketscreener.com
DEADLINE ALERT for TMCI, IBTA, and NPWR: The Law Offices of - GlobeNewswire
Shareholders of Treace Medical Concepts, Inc. (TMCI): Protect Your Rights Before June 10, 2025Contact Levi & Korsinsky - ACCESS Newswire
TMCI FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important June 10 Deadline in Securities Class ActionTMCI - ACCESS Newswire
FINAL TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Treace Medical Concepts, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FinancialContent
Recover Investment Losses: Levi & Korsinsky Files Class Action Against Treace Medical Concepts, Inc. (TMCI) - ACCESS Newswire
Treace Medical Concepts, Inc. Sued for Securities Law - GlobeNewswire
Treace Medical Concepts, Inc. Sued for Securities Law Violations – Investors Should Contact The ... - Bluefield Daily Telegraph
Treace Medical Concepts, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – TMCI - TradingView
트리스 메디컬 컨셉트 (TMCI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.67%
0.94%
자본화:
|
볼륨(24시간):